Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_4
1
33%
Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Other(3)

Detailed Status

unknown3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

unknown3100%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Cardiovascular Risk Reduction in Atrial Fibrillation Trial

NCT04347330
unknownnot_applicable

Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients

NCT03015311
unknownphase_4

Feasibility Study of the Intensive Systolic Blood Pressure Control

NCT02817503

Clinical Trials (3)

Showing 3 of 3 trials
NCT04347330Not Applicable

Cardiovascular Risk Reduction in Atrial Fibrillation Trial

Unknown
NCT03015311Not Applicable

Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients

Unknown
NCT02817503Phase 4

Feasibility Study of the Intensive Systolic Blood Pressure Control

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3